Pedro Eerdmans

3.8k citations

17 papers · 1.4k indexed · 1 hit paper · h-index 12

Urology top 1%
Cardiology and Cardiovascular Medicine top 2%
- Cardiac Valve Diseases and Treatments 4
- Antiplatelet Therapy and Cardiovascular Diseases 2
Surgery top 5%
- Coronary Interventions and Diagnostics 8
- Peripheral Artery Disease Management 2
Rheumatology top 5%
- Pelvic floor disorders treatments 3
Pulmonary and Respiratory Medicine top 10%
- Cerebrovascular and Carotid Artery Diseases 3
Physiology
- Nitric Oxide and Endothelin Effects 4
Molecular Biology
- Receptor Mechanisms and Signaling 2

Co-authors: E.H.J. Weil R.A. Janknegt Stephan Windecker Carlo Di Mario Peter Jüni Robert‐Jan van Geuns Marie‐Claude Morice Roberto Corti
Cited by: Urology Cardiology and Cardiovascular Medicine Surgery
Partner nations: Netherlands Switzerland United Kingdom

In The Last Decade

Pedro Eerdmans

17 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2008 Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

Peers

Countries citing papers authored by Pedro Eerdmans

Since Specialization

Citations

This map shows the geographic impact of Pedro Eerdmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Eerdmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Eerdmans more than expected).

Fields of papers citing papers by Pedro Eerdmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Eerdmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Eerdmans. The network helps show where Pedro Eerdmans may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Pedro Eerdmans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pedro Eerdmans Line = papers co-authored together Pedro Eerdmans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial Janusz Lipiecki,Philippe Brunel,Marie‐Claude Morice,Christan Roguelov,Simon Walsh,Gert Richardt,Pedro Eerdmans,Robaayah Zambahari,Jacques Berland,Samuel Copt,Hans‐Peter Stoll,Philip Urban	2018	19
2	Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial Matteo Ghione,Joanna J. Wykrzykowska,Stephan Windecker,Patrick W. Serruys,Paweł Buszman,Axel Linke,Hae Young Sohn,Roberto Corti,Diethmar Antoni,William Wijns,Rodrigo Estévez‐Loureiro,Marie‐Claude Morice,Gerrit‐Anne van Es,Robert‐Jan van Geuns,Peter Jüni,Pedro Eerdmans,Ton de Vries,Stéphanie Konik,Carlo Di Mario	2016	4
3	Outcomes following implantation of the biolimus A9‐eluting BioMatrix coronary stent: Primary analysis of the e‐BioMatrix registry Philip Urban,Mariano Valdés,Ian Menown,Franz R. Eberli,Imad A. Alhaddad,David Hildick‐Smith,David G. Iosseliani,Marco Roffi,Keith G. Oldroyd,Erifyli Kalloudi,Pedro Eerdmans,Jacques Berland,Franz X. Kleber,(unknown)	2015	9
4	Biolimus-eluting stent with biodegradable polymer improves clinical outcomes in patients with acute myocardial infarction Yao‐Jun Zhang,Javaid Iqbal,Stephan Windecker,Axel Linke,Diethmar Antoni,Hae Young Sohn,Roberto Corti,Gerrit‐Anne van Es,Samuel Copt,Pedro Eerdmans,R Saitta,Marie‐Claude Morice,Carlo Di Mario,Peter Jüni,William Wijns,Paweł Buszman,Patrick W. Serruys	2014	12
5	Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial Giulio Stefanini,Bindu Kalesan,Patrick W. Serruys,Dik Heg,Paweł Buszman,Axel Linke,Thomas Ischinger,Volker Klauß,Franz R. Eberli,William Wijns,Marie‐Claude Morice,Carlo Di Mario,Roberto Corti,Diethmar Antoni,Hae Young Sohn,Pedro Eerdmans,Gerrit‐Anne van Es,Bernhard Meier,Stephan Windecker,Peter Jüni	2011	245
6	The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer Scot Garg,Giovanna Sarno,Patrick Serruys,Ton de Vries,Paweł Buszman,Axel Linke,Thomas Ischinger,Volker Klauß,Franz R. Eberli,Roberto Corti,William Wijns,Marie‐Claude Morice,Carlo Di Mario,Robert‐Jan van Geuns,Pedro Eerdmans,Gerrit-Anne van Es,Bernhard Meier,Peter Jüni,Stephan Windecker	2010	39
7	An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study Peter Barlis,E. Regar,Patrick W. Serruys,Konstantinos Dimopoulos,Wim J. van der Giessen,Robert‐Jan van Geuns,Giuseppe Ferrante,Simon Wandel,Stephan Windecker,G.-A. van Es,Pedro Eerdmans,Peter Jüni,Carlo Di Mario	2009	185
8	Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trialbreakdown → Stephan Windecker,Patrick W. Serruys,Simon Wandel,Paweł Buszman,Stanisław Trznadel,Axel Linke,Karsten Lenk,Thomas Ischinger,Volker Klauß,Franz R. Eberli,Roberto Corti,William Wijns,Marie‐Claude Morice,Carlo Di Mario,Simon Davies,Robert‐Jan van Geuns,Pedro Eerdmans,Gerrit-Anne van Es,Bernhard Meier,Peter Jüni	2008	453
9	Sacral Root Neuromodulation in the Treatment of Refractory Urinary Urge Incontinence: A Prospective Randomized Clinical Trial E.H.J. Weil,J.L. Ruiz-Cerd aacute,Pedro Eerdmans,R.A. Janknegt,Bart L.H. Bemelmans,P.E.V. Van Kerrebroeck	2000	141
10	Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes E.H.J. Weil,J.L. Ruiz-Cerdá,Pedro Eerdmans,R.A. Janknegt,Philip E.V.A. van Kerrebroeck	1998	99
11	Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study E.H.J. Weil,Pedro Eerdmans,G.A. Dijkman,Karl Tamussino,Jaroslav Feyereisl,Mark E. Vierhout,Caroline Schmidbauer,Christian Egarter,D. Kölle,J. E. M. H. Plasman,H. Heidler,Brigitt Abbühl,Wolfgang Wein	1998	21
12	Improving neuromodulation technique for refractory voiding dysfunctions: Two-stage implant R.A. Janknegt,E.H.J. Weil,Pedro Eerdmans	1997	151
13	Impaired arterial reactivity following cytomegalovirus infection in the immunosuppressed rat Pedro Eerdmans,M. Persoons,Sjaak J.M. Debets,Harry A.J. Struijker Boudier,Jos F.M. Smits,Catrien Bruggeman,Jo G. R. De Mey	1996	5
14	Mechanisms of renal vasoconstriction following furosemide in conscious rats Ben Janssen,Pedro Eerdmans,Jos F.M. Smits	1994	14
15	Mesenteric Small Artery Changes After Vasoconstrictor Infusion in Young Rats Harrie C. M. Boonen,Mat J.A.P. Daemen,Pedro Eerdmans,Gregorio E. Fazzi,Ellen M. van Kleef,Paul Schiffers,Jo G. R. De Mey	1993	28
16	Contractile reactivity of isolated resistance arteries after 4 weeks of treatment with rilmenidine, clonidine or hydralazine in spontaneously hypertensive rats Pedro Eerdmans,H.A.J. Struyker Boudier,Jo G. R. De Mey	1991	1
17	Contractile reactivity of isolated resistance arteries after 4 weeks of treatment with rilmenidine, clonidine or hydralazine in spontaneously hypertensive rats Pedro Eerdmans,H.A.J. Struyker Boudier,Jo G. R. De Mey	1991	5

About Pedro Eerdmans

Pedro Eerdmans is a scholar working on Cardiology and Cardiovascular Medicine, Urology and Surgery, having authored 17 papers that have together received 1.4k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (8 papers), Nitric Oxide and Endothelin Effects (4 papers), Cardiac Valve Diseases and Treatments (4 papers), Pelvic floor disorders treatments (3 papers), Cerebrovascular and Carotid Artery Diseases (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Peripheral Artery Disease Management (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Urology (358 citations), Cardiology and Cardiovascular Medicine (715 citations) and Surgery (1.1k citations). Pedro Eerdmans has collaborated with scholars based in Netherlands, Switzerland and United Kingdom. Frequent co-authors include E.H.J. Weil, R.A. Janknegt, Stephan Windecker, Carlo Di Mario, Peter Jüni, Robert‐Jan van Geuns, Marie‐Claude Morice, Roberto Corti, Franz R. Eberli and Paweł Buszman.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact